E I Astashkin Selected Research

Actovegin

5/2014	Actovegin reduces the hydrogen peroxide-induced cell apoptosis of SK-N-SH neuroblastoma by means of p38MAPK and PI-3K inhibition.
1/2014	[New approaches in the regulation of blood phagocytes and reduction in the formation of oxygen radicals in patients with heart failure].
1/2013	Actovegin reduces the ROS level in blood samples of heart failure patients and diminishes necrosis of SK-N-SH human neuroblastoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

E I Astashkin Research Topics

Disease

4	Neuroblastoma 05/2014 - 01/2013
3	Necrosis 01/2014 - 01/2013
2	Acute Coronary Syndrome 01/2016 - 01/2015
2	Ischemia 01/2016 - 01/2014
2	Heart Failure 01/2014 - 01/2013
1	Myocardial Infarction 01/2015
1	Unstable Angina 01/2015
1	Hepatitis 01/2014
1	Inflammation (Inflammations) 01/2014
1	Herpes Simplex 01/2014
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Leukemia 05/2006
1	Coronary Disease (Coronary Heart Disease) 01/2006
1	Pheochromocytoma 07/2000

Drug/Important Bio-Agent (IBA)

3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2014 - 01/2014
3	ActoveginIBA 05/2014 - 01/2013
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2016 - 01/2015
2	Propidium (Propidium Iodide)IBA 01/2014 - 01/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2014 - 01/2006
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 05/2014
1	Antiviral Agents (Antivirals)IBA 01/2014
1	Shiga Toxins (Vero Toxin)IBA 01/2008
1	Peptides (Polypeptides)IBA 05/2006
1	Adenosine Triphosphate (ATP)IBA 07/2000

Therapy/Procedure

1	Conservative Treatment 01/2016